All In MedTech

Device Trial Radar · NCT05714501

Millipede AspiRation for Revascularization in Stroke (MARRS) Study

Last checked: Nov 19, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

235

Actual

Start

Oct 9, 2023

Primary completion

Mar 8, 2025

Study completion May 12, 2025

Sponsor

Lead sponsor
PerfuzeNot on our public-company list
Sponsor type
Industry
First posted
Feb 6, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objectives of the study are to examine the performance and safety characteristics of the Millipede System when used for revascularization of patients with acute ischemic stroke due to Large Vessel Occlusions (LVOs) and to record associated clinical outcomes.

Conditions

  • Acute Ischemic Stroke

Interventions

  • Millipede SystemDevice

    Mechanical thrombectomy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ITT Cohort: Rate of Core Lab-adjudicated Reperfusion Success Within Three PassesTime frame: Intraprocedural
  2. ITT Cohort: Primary Safety OutcomeTime frame: From Day 0 (procedure) through to the 90 Day visit.
  3. ITT Cohort: Supplementary Analysis of Primary Effectiveness EndpointTime frame: Intraprocedural

3 more outcomes with a free account

Locations

23 sites in 3 countries. Site status is shown where the registry gives one.

  • Yale University Hospital

    New Haven, Connecticut

  • Baptist Health Research Institute

    Jacksonville, Florida

  • Tampa General Hosital

    Tampa, Florida

20 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.